Streetbeat News

Price Targets

ADC

BV

CCOI

DRMA

ENPH

GLW

MDT

SON

TXN

VIPS

Top Wall Street analysts have updated their outlooks on several companies, including Texas Instruments, BrightView Holdings, Sonoco Products, Medtronic, Enphase Energy, Cogent Communications, Corning, Vipshop Holdings, Agree Realty, and Dermata Therapeutics. Notable changes include Citigroup upgrading Texas Instruments to Buy with a price target increase to $235, and B of A Securities downgrading Cogent Communications to Underperform with a price target cut to $65.

Portfolio Pulse from Avi Kapoor

August 21, 2024 | 12:58 pm

LOW

Telsey Advisory Group has maintained its Market Perform rating on Lowe's Companies, with a price target of $230.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:57 pm

SGHT

Lake Street has initiated coverage on Sight Sciences with a Buy rating and set a price target of $10.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:52 pm

LOW

Wedbush analyst Seth Basham has reiterated a Neutral rating for Lowe's Companies (NYSE:LOW) and maintained a price target of $250.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:51 pm

LIF

Loop Capital has maintained a Buy rating on Life360 and increased its price target from $36 to $43, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:49 pm

SNOW

Loop Capital has maintained a Buy rating on Snowflake but lowered its price target from $225 to $185, indicating a more cautious outlook.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:47 pm

GLW

Corning's stock received a boost after Mizuho upgraded its rating from Neutral to Outperform and increased its price target from $44 to $47.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:46 pm

TTWO

Wedbush analyst Nick McKay has reiterated an 'Outperform' rating for Take-Two Interactive, maintaining a price target of $190.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:46 pm

RKDA

HC Wainwright & Co. has reiterated its Buy rating on Arcadia Biosciences (NASDAQ:RKDA) and maintained a price target of $6, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:43 pm

CLGN

HC Wainwright & Co. has reiterated its Buy rating for CollPlant Biotechnologies, maintaining a price target of $11. This suggests confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:40 pm